Aims To evaluate the prevalence and the clinical implication of persistently elevated liver enzymes in diabetic subjects, with no evidence of viral hepatitis infection or alcohol abuse. Methods Clinical, lifestyle, anthropometric data and laboratory test values were collected in 916 type 2 diabetic subjects, examined for alanine aminotransferase (ALT), aspartate aminotransferase (AST) and γ-glutamyltranspeptidase (γ-GT) levels at two different time points. Results Five hundred forty four patients (59.4%) showed normal (NLT group) and 182 (19.9%) persistently elevated (ELT group) liver tests in both determinations. ELT patients were prevalently men (P = 0.016), younger (P < 0.0001) and with a lower duration of diabetes (P = 0.008). Adjusting for age and sex, ELT subjects had significantly higher BMI (P < 0.001), waist circumference (P = 0.010), systolic (P = 0.017) and diastolic blood pressure (P < 0.001), and higher levels of fasting blood glucose (P = 0.023), and triglycerides (P < 0.0001). Current hypoglycemic and/or hypolipidemic drugs were comparable between the two groups. At multivariate analysis, male gender (OR = 3.017, P = 0.012), worse metabolic control (HbA1c, OR = 1.408, P = 0.017), and a younger age (OR = 1.054, P = 0.007) predicted the presence of persistently elevated liver enzymes. Conclusions Persistently elevated liver enzymes are a common finding in outpatient type 2 diabetic subjects, particularly in young men with suboptimal metabolic control and with the features of metabolic syndrome. The persistence of abnormal liver tests may be of potential utilization in clinical practice for the screening of patients at high risk of NAFLD.

Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients

GIANDALIA, ANNALISA;ROMEO, ELISABETTA LUCIA;RUFFO, MARIA CONCETTA;MUSCIANISI, MARCO;FORTE, Fiorella;CUCINOTTA, Domenico Maria;RUSSO, GIUSEPPINA
2016-01-01

Abstract

Aims To evaluate the prevalence and the clinical implication of persistently elevated liver enzymes in diabetic subjects, with no evidence of viral hepatitis infection or alcohol abuse. Methods Clinical, lifestyle, anthropometric data and laboratory test values were collected in 916 type 2 diabetic subjects, examined for alanine aminotransferase (ALT), aspartate aminotransferase (AST) and γ-glutamyltranspeptidase (γ-GT) levels at two different time points. Results Five hundred forty four patients (59.4%) showed normal (NLT group) and 182 (19.9%) persistently elevated (ELT group) liver tests in both determinations. ELT patients were prevalently men (P = 0.016), younger (P < 0.0001) and with a lower duration of diabetes (P = 0.008). Adjusting for age and sex, ELT subjects had significantly higher BMI (P < 0.001), waist circumference (P = 0.010), systolic (P = 0.017) and diastolic blood pressure (P < 0.001), and higher levels of fasting blood glucose (P = 0.023), and triglycerides (P < 0.0001). Current hypoglycemic and/or hypolipidemic drugs were comparable between the two groups. At multivariate analysis, male gender (OR = 3.017, P = 0.012), worse metabolic control (HbA1c, OR = 1.408, P = 0.017), and a younger age (OR = 1.054, P = 0.007) predicted the presence of persistently elevated liver enzymes. Conclusions Persistently elevated liver enzymes are a common finding in outpatient type 2 diabetic subjects, particularly in young men with suboptimal metabolic control and with the features of metabolic syndrome. The persistence of abnormal liver tests may be of potential utilization in clinical practice for the screening of patients at high risk of NAFLD.
2016
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3103424
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact